Follicle‐stimulating hormone effectiveness in male idiopathic infertility: What happens in daily practice?

To assess the effectiveness of follicle‐stimulating hormone (FSH) administration in male idiopathic infertility in a clinical setting.

[1]  Claudio Baraldi,et al.  Qualitative and quantitative analysis of doctor–patient interactions during andrological consultations , 2022, Andrology.

[2]  D. Santi,et al.  Real-world evidence analysis of the follicle-stimulating hormone use in male idiopathic infertility. , 2022, Best practice & research. Clinical obstetrics & gynaecology.

[3]  S. Heilmann-Heimbach,et al.  A GWAS in Idiopathic/Unexplained Infertile Men Detects a Genomic Region Determining Follicle-Stimulating Hormone Levels , 2022, The Journal of clinical endocrinology and metabolism.

[4]  M. Simoni,et al.  Management of male factor infertility: position statement from the Italian Society of Andrology and Sexual Medicine (SIAMS) , 2022, Journal of Endocrinological Investigation.

[5]  I. Huhtaniemi,et al.  The Roles of Luteinizing Hormone, Follicle-Stimulating Hormone and Testosterone in Spermatogenesis and Folliculogenesis Revisited , 2021, International journal of molecular sciences.

[6]  D. Santi,et al.  Are sperm parameters able to predict the success of assisted reproductive technology? A retrospective analysis of over 22,000 assisted reproductive technology cycles , 2021, Andrology.

[7]  A. Salonia,et al.  European Association of Urology Guidelines on Male Sexual and Reproductive Health: 2021 Update on Male Infertility. , 2021, European urology.

[8]  Qi Ying Lean,et al.  Effectiveness of Pharmacological Intervention Among Men with Infertility: A Systematic Review and Network Meta-Analysis , 2021, Frontiers in Pharmacology.

[9]  Hongcheng Luo,et al.  Associations of serum estradiol level, serum estrogen receptor-alpha level, and estrogen receptor-alpha polymorphism with male infertility , 2021, Medicine.

[10]  Richard M Yanofsky,et al.  Business law issues for assisted reproductive technology practices and practitioners: considerations for sales or mergers of fertility practices. , 2020, Fertility and sterility.

[11]  Wim Goettsch,et al.  Improving transparency to build trust in real‐world secondary data studies for hypothesis testing—Why, what, and how: recommendations and a road map from the real‐world evidence transparency initiative , 2020, Pharmacoepidemiology and drug safety.

[12]  D. Santi,et al.  Follicle-Stimulating Hormone (FSH) Action on Spermatogenesis: A Focus on Physiological and Therapeutic Roles , 2020, Journal of clinical medicine.

[13]  D. Santi,et al.  FSH for the Treatment of Male Infertility , 2020, International journal of molecular sciences.

[14]  A. Calogero,et al.  Molecular Biology of Spermatogenesis: Novel Targets of Apparently Idiopathic Male Infertility , 2020, International journal of molecular sciences.

[15]  D. Santi,et al.  The physician's gender influences the results of the diagnostic workup for erectile dysfunction , 2020, Andrology.

[16]  D. Santi,et al.  FSH treatment of male idiopathic infertility: Time for a paradigm change , 2019, Andrology.

[17]  C. D. De Jonge,et al.  The present crisis in male reproductive health: an urgent need for a political, social, and research roadmap , 2019, Andrology.

[18]  M. Maggi,et al.  Both comorbidity burden and low testosterone can explain symptoms and signs of testosterone deficiency in men consulting for sexual dysfunction , 2019, Asian journal of andrology.

[19]  A. Calogero,et al.  FSH therapy for idiopathic male infertility: four schemes are better than one , 2019, The aging male : the official journal of the International Society for the Study of the Aging Male.

[20]  V. Korsak,et al.  The International Glossary on Infertility and Fertility Care , 2019, Problemy reproduktsii.

[21]  I. Huhtaniemi,et al.  Role of Follicle-Stimulating Hormone in Spermatogenesis , 2018, Front. Endocrinol..

[22]  D. Goulis,et al.  European Academy of Andrology guideline Management of oligo‐astheno‐teratozoospermia , 2018, Andrology.

[23]  C. Krausz,et al.  Genetics of male infertility , 2018, Nature Reviews Urology.

[24]  L. Rienzi,et al.  The International Glossary on Infertility and Fertility Care, 2017 , 2017, Human reproduction.

[25]  David Madigan,et al.  Good practices for real‐world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR‐ISPE Special Task Force on real‐world evidence in health care decision making , 2017, Pharmacoepidemiology and drug safety.

[26]  E. Žatecká,et al.  Of Oestrogens and Sperm: A Review of the Roles of Oestrogens and Oestrogen Receptors in Male Reproduction , 2017, International journal of molecular sciences.

[27]  Roberto Pontarolo,et al.  Network meta-analysis: a technique to gather evidence from direct and indirect comparisons , 2017, Pharmacy practice.

[28]  H. Hillege,et al.  Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies. , 2016, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[29]  D. Santi,et al.  Primary and Secondary Hypogonadism , 2017 .

[30]  E. Baldi,et al.  Treatment with human, recombinant FSH improves sperm DNA fragmentation in idiopathic infertile men depending on the FSH receptor polymorphism p.N680S: a pharmacogenetic study. , 2016, Human reproduction.

[31]  Wan-long Tan,et al.  Treatment of idiopathic oligozoospermia with recombinant human follicle‐stimulating hormone: a prospective, randomized, double‐blind, placebo‐controlled clinical study in Chinese population , 2015, Clinical endocrinology.

[32]  D. Santi,et al.  FSH treatment of male idiopathic infertility improves pregnancy rate: a meta-analysis , 2015, Endocrine connections.

[33]  E. Sabanegh,et al.  Analysis of semen parameters in male referrals: impact of reference limits, stratification by fertility categories, predictors of change, and comparison of normal semen parameters in subfertile couples. , 2015, Fertility and sterility.

[34]  E. Mannucci,et al.  Factors affecting spermatogenesis upon gonadotropin‐replacement therapy: a meta‐analytic study , 2014, Andrology.

[35]  L. Finos,et al.  Spermatid count as a predictor of response to FSH therapy. , 2014, Reproductive biomedicine online.

[36]  E. Vicari,et al.  Follicle-stimulating hormone treatment in normogonadotropic infertile men , 2013, Nature Reviews Urology.

[37]  N. Colacurci,et al.  Recombinant human FSH reduces sperm DNA fragmentation in men with idiopathic oligoasthenoteratozoospermia. , 2012, Journal of andrology.

[38]  S. Carreau,et al.  Estrogen, a female hormone involved in spermatogenesis. , 2012, Advances in medical sciences.

[39]  A. Frigo,et al.  Toward a pharmacogenetic approach to male infertility: polymorphism of follicle-stimulating hormone beta-subunit promoter. , 2011, Fertility and sterility.

[40]  C. Foresta,et al.  The response to FSH treatment in oligozoospermic men depends on FSH receptor gene polymorphisms. , 2011, International journal of andrology.

[41]  Organización Mundial de la Salud.  WHO laboratory manual for the examination and processing of human semen , 2010 .

[42]  Roelof Menkveld,et al.  Clinical significance of the low normal sperm morphology value as proposed in the fifth edition of the WHO Laboratory Manual for the Examination and Processing of Human Semen. , 2010, Asian journal of andrology.

[43]  Y. Ogawa,et al.  Does a clinical varicocele influence the relationship between testicular volume by ultrasound and testicular function in patients with infertility? , 2009, Fertility and sterility.

[44]  C. Foresta,et al.  Gonadotropin administration after gonadotropin-releasing-hormone agonist: a therapeutic option in severe testiculopathies. , 2009, Fertility and sterility.

[45]  C. Stocco.  Aromatase expression in the ovary: Hormonal and molecular regulation , 2008, Steroids.

[46]  C. Farquhar,et al.  Gonadotrophins for idiopathic male factor subfertility. , 2007, The Cochrane database of systematic reviews.

[47]  T. Mayhew,et al.  Estrogenic induction of spermatogenesis in the hypogonadal (hpg) mouse: role of androgens. , 2005, Reproduction.

[48]  C. Foresta,et al.  Treatment of male idiopathic infertility with recombinant human follicle-stimulating hormone: a prospective, controlled, randomized clinical study. , 2005, Fertility and sterility.

[49]  P. Piomboni,et al.  Effect of follicle-stimulating hormone on sperm quality and pregnancy rate. , 2004, Asian journal of andrology.

[50]  C. Niederberger,et al.  Male infertility. , 2006, Reviews in urology.

[51]  C. Niederberger,et al.  Recombinant human follicle-stimulating hormone as a pretreatment for idiopathic oligoasthenoteratozoospermic patients undergoing intracytoplasmic sperm injection. , 2003, Fertility and sterility.

[52]  C. Foresta,et al.  Use of recombinant human follicle-stimulating hormone in the treatment of male factor infertility. , 2002, Fertility and sterility.

[53]  K. Kula,et al.  Estradiol enhances the stimulatory effect of FSH on testicular maturation and contributes to precocious initiation of spermatogenesis , 2001, Molecular and Cellular Endocrinology.

[54]  M. Plebani,et al.  FSH in the treatment of oligozoospermia , 2000, Molecular and Cellular Endocrinology.

[55]  S. Carreau.  Estrogens and male reproduction. , 2000, Folia histochemica et cytobiologica.

[56]  J. Jarow.  Follicle-stimulating hormone treatment for men with idiopathic oligoteratoasthenozoospermia before in vitro fertilization: the impact on sperm microstructure and fertilization potential. , 2000, The Journal of urology.

[57]  Z. Ben-Rafael,et al.  The role of purified follicle stimulating hormone therapy in the male partner before intracytoplasmic sperm injection. , 1999, Fertility and sterility.

[58]  E. Nieschlag,et al.  Recombinant human follicle stimulating hormone for treatment of male idiopathic infertility: a randomized, double-blind, placebo-controlled, clinical trial. , 1998, Human reproduction.

[59]  B. Lunenfeld,et al.  Sperm quality of subfertile males before and after treatment with human follicle‐stimulating hormone , 1994, Fertility and sterility.

[60]  E H Wagner,et al.  A chronic disease score from automated pharmacy data. , 1992, Journal of clinical epidemiology.